Boston, MA 08/15/2014 (wallstreetpr) – Are head fund companies made a big money out of Allergan, Inc. (NYSE:AGN)’s potential bid to be sold or a takeover target company? If so, are the investors taken for a ride? If reports are to be believed, the regulator, Securities Exchange Commission or the SEC, seemed to have seized […]
